These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8927194)

  • 1. [Primary and secondary negative symptoms: a useful differentiation? An empirical study].
    Barnett W; Mundt C; Richter P
    Nervenarzt; 1996 Jul; 67(7):558-63. PubMed ID: 8927194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rumination and negative symptoms in schizophrenia.
    Halari R; Premkumar P; Farquharson L; Fannon D; Kuipers E; Kumari V
    J Nerv Ment Dis; 2009 Sep; 197(9):703-6. PubMed ID: 19752652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms of schizophrenia: a problem that will not go away.
    Stahl SM; Buckley PF
    Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Locus of control in chronic schizophrenia. Empirical data in an ambulatory group of patients].
    Lasar M; Loose R
    Nervenarzt; 1994 Jul; 65(7):464-9. PubMed ID: 7800090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of primary negative symptoms in schizophrenic and other psychiatric patients].
    Gerbaldo H; Müller-Siecheneder F
    Fortschr Neurol Psychiatr; 1996 Jun; 64(6):221-7. PubMed ID: 8766995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between cognitive deficits and schizophrenic symptoms].
    Kukla F
    Z Psychol Z Angew Psychol; 1992; 200(1):37-44. PubMed ID: 1351695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodological constraints in evaluating anti-deficit effects].
    Boyer P; Lecrubier Y; Rein W
    Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
    Kahn JP
    Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive deficit changes in relation to the course of schizophrenia and schizophrenia spectrum disorders: 5-year follow-up study.
    Zaytseva Y; Korsakova NK; Gurovich IY
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S149-51. PubMed ID: 21057427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
    Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
    Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia.
    Brébion G; Amador X; Smith M; Malaspina D; Sharif Z; Gorman JM
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):177-83. PubMed ID: 10910088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
    Petit M; Langlois S
    Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping style and cognitive dysfunction in schizophrenic patients.
    van den Bosch RJ; van Asma MJ; Rombouts R; Louwerens JW
    Br J Psychiatry Suppl; 1992 Oct; (18):123-8. PubMed ID: 1389035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.